Plasma, Urinary, and Erythrocyte Concentrations of Guanidino Compounds in Patients with Chronic Renal Failure

References

• Stein I M, Perez G, Johnson R, et al. Serum levels and urinary excretion of methylguanidine in chronic renal failure. J Lab Clin Med 1971; 77: 1020–1024
   PubMedGoogle Scholar
• Menichini G C, Gonella M, Barsotti G, et al. Determination of methylguanidine in serum and urine from normal and uremic subjects. Experientia 1971; 15: 1157–1158
   Google Scholar
• Giovannetti S, Biagini M, Cioni L. Evidence that methylguanidine is retained in chronic renal failure. Fxprientiau 1968; 15: 341–342
   Google Scholar
• Baker L RI, Marshall R D. A reinvestigation of methylguanidine concentrations in sera from normal and uremic subjects. Clin Sci 1971; 41: 563–568
   PubMedGoogle Scholar
• Stein I M, Cohen B D, Komhauser R S. Guanidinosuccinic acid in renal failure. experimental azotemia and inborn errors of the urea cycle. N Engl J Med 1969; 280: 926–930
   PubMed Web of Science ®Google Scholar
• Stein I M, Cohen B D, Horowitz H. Guanidinosuccinic acid: ‘X’ factor in uremic bleeding?. Clin Res 1968; 16: 397
   Google Scholar
• Minot A, Dodd K. Guanidino intoxication. Am J Dis Child 1933; 46: 522–527
   Google Scholar
• Giovannetti S, Cioni L, Balestri P L, et al. Evidence that guanidines and some related compounds cause hemolysis in chronic uremia. Clin Sci 1968; 34: 141–148
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Saito A, Manji T, et al. Quantitative analysis of methylguanidine and guanidine in physiologic fluids by high-performance liquid chromatography-fluorescence detection method. J Chromatogr 1979; 162: 23–29
   PubMed Web of Science ®Google Scholar
• Bonas J E, Cohen B D, Natelson S. Separation and estimation of cartain, Wanidino compounds. Application to human urine. Microchem J 1963; 7: 63–77
   Google Scholar
• Natelson S, Stein I, Bonas J E. Improvements in the method of separation of guanidino organic acids by column chromatography. Isolation and identification of guanidinosuccinic acid from human urine. Microchem J 1964; 8: 371–382
   Google Scholar
• Kikuchi T, Orita Y, Ando A, et al. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocytes of normal persons and uremic patients. Clin Chem 1981; 27: 1899–1902
   PubMed Web of Science ®Google Scholar
• Horowitz H L. Uremictoxins and platelet functions. Arch Int Med 1970; 7: 823
   Google Scholar
• Slavin R G, Fitch C D. Inhibition of lympmocyte transformation by guanidinosuccinic acid, a surplus metabolite in uremia. Experrentia 1971; 27: 1340
   PubMedGoogle Scholar
• Cohen B D, Stein I M, Bonas J E. Guanidinosuccinic aciduria in uremia. a possible alternate pathway for urea synthesis. Am J Med 1968; 45: 53–68
   Google Scholar
• Natelson S, Sherwin J E. Proposed mechanism for urea nitrogen reutilization: Relationship between urea and proposed guanidine cycles. Clin Chem 1979; 25: 1343–1344
   PubMed Web of Science ®Google Scholar
• Aoyagi K, Ohba S, Narita M, et al. Regulation of biospthesis of guanidinosuccinic acid in isolated rat hepatocytes and in vivo. Kidney Int 1983; 24: S224–S228
   Google Scholar
• Giovannetti S, Balestri P L, Barsotti G. Methylguanidine in uremia. Arch Intern Med 1973; 131: 709–713
   PubMedGoogle Scholar
• Barsotti G, Bevilacqua G, Morelli E, et al. Toxicity arising from guanidine compounds: Role of methylguanidne as a uremic toxin. Kidney Int 1975; 7: S299–S301
   Google Scholar
• Giovannetti S, Biagini M, Valestri P L, et al. Uremia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine. Clin Sci 1969; 36: 445–452
   PubMed Web of Science ®Google Scholar
• Nagase S, Aoyagi K, Narita M, et al. Biosynthesis of methylguanidine in isolated rat hepatocytes and in vivo. Nephron 1985; 40: 470–475
   PubMed Web of Science ®Google Scholar
• Aoyagi K, Nagase S, Narita M, et al. Role of active oxygen on methylguanidine synthesis in isolated rat hepatocytes. Kidney Int 1987; 32: S229–S233
   Google Scholar
• Nakamura K, Ienaga K, Yokozawa T, et al. Produdion of methylguanidine from creatinine via creatol by adive oxygen species: analyses of the catabolism in vitro. Nephron 1991; 58: 42–46
   PubMed Web of Science ®Google Scholar
• Nakamura K, Ienaga K, Nakano K, et al. Creatol, a creatinine metabolite, as a useful determinant of renal function. Nephron 1994; 66: 140–146
   PubMed Web of Science ®Google Scholar
• Borsook H, Dubnoff J W. The formation of glycocyamine in animal tissues. J Biol Chem 1941; 138: 389–403
   Google Scholar
• Im Y S, Chiang P K, Cantoni G L. Guanidinoacetate methyltransferase. Purification and molecular properties. J Biol Chem 1979; 254: 11047–11050
   PubMedGoogle Scholar
• Takeda M, Kiyatake I, Koide H, et al. Biosynthesis of guanidinoacetic acid in isolated renal tubules. Eur J Clin Chem Clin Biochem 1992; 30: 325–331
   PubMedGoogle Scholar
• Takeda M, Koide H, Jung K Y, et al. Intranephron distribution of glycine-amidinotransferase activity in rats. Renal Physiol Biochem 1992; 15: 113–118
   PubMedGoogle Scholar
• Walker J B. Famadine group transfer in exads of human pancreas, liver, and kidney. Biochim Biophys Acta 1963; 73: 241–247
   PubMedGoogle Scholar
• Shainkin R, Giatt Y, Berlyne G M. The presence and toxicity of guanidmo-propionic acid in uremia. Kidney Int 1975; 7: S302–S305
   Google Scholar
• Gurreri G, Ghiggeri G, Salvidio G, et al. Effect of hemodialysis on guanidinopropionic acid metabolism. Nephron 1986; 42: 295–297
   PubMedGoogle Scholar
• De Deyn P, Marescau B, Lornoy W, et al. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis. Nephron 1987; 45: 291–295
   PubMedGoogle Scholar
• Perez G, Abraira C, Rey A, et al. Removal of guanidinosuccinic acid by hemodialysis. Nephron 1977; 19: 214–219
   PubMedGoogle Scholar